Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00440_DB00712_nanopub.RABqWm9M8FPYCHv6SkG7ScSWxpe-blh9sVMK5bhZ4h_34#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00440_DB00712 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00440_DB00712 label "DDI between Trimethoprim and Flurbiprofen - The strong CYP2C9 inhibitor, Flurbiprofen, may decrease the metabolism and clearance of Trimethoprim, a CYP2C9 substrate. Consider alternate therapy or monitor for changes in therapeutic and adverse effects of Trimethoprim if Flurbiprofen is initiated, discontinued or dose changed. [drugbank_resource:DB00440_DB00712]" assertion.
- drugbank_resource:DB00440_DB00712 identifier "drugbank_resource:DB00440_DB00712" assertion.
- drugbank_resource:DB00440_DB00712 title "DDI between Trimethoprim and Flurbiprofen - The strong CYP2C9 inhibitor, Flurbiprofen, may decrease the metabolism and clearance of Trimethoprim, a CYP2C9 substrate. Consider alternate therapy or monitor for changes in therapeutic and adverse effects of Trimethoprim if Flurbiprofen is initiated, discontinued or dose changed." assertion.
- drugbank:DB00440 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00440_DB00712 assertion.
- drugbank:DB00712 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00440_DB00712 assertion.